Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2112 (LINC02112)

Target
LINC02112
Molecular classification
Other (long intergenic non-coding RNA)
01

Overview

Long intergenic non-protein coding RNA 2112 (LINC02112), also known as CTD-2143L24.1, is a member of the long intergenic non-coding RNA (lincRNA) family. LincRNAs are defined as autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes. They are primarily involved in chromatin remodeling, regulation of transcription, RNA stabilization, and modulation of gene expression, often in a tissue-specific manner. Most lincRNAs do not encode proteins and their functions can include acting as molecular scaffolds or modulating signaling pathways, although the biological role of many individual lincRNAs, including LINC02112, remains poorly characterized. There is currently no evidence that LINC02112 is a clinically established therapeutic target, nor are there approved drugs or biomarkers directly related to it. The field is evolving, and lincRNAs are increasingly recognized as important regulators in gene expression and potentially in human disease, but the specific functions and disease associations of LINC02112 have yet to be firmly established[1][3][7].

Other names
CTD-2143L24.1LINC02112
02

Biological functions

Chromatin remodelingRegulation of transcriptionRNA stabilizationFine-tuning expression of neighboring genes
03

Disease associations

Other (Diverse, context-dependent; specific disease roles of LINC02112 not established in current literature)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2112 (LINC02112).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2112 (LINC02112).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call